Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Cognitive Function in Schizophrenia
NCT01093365Phase 2Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Mar 2010
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline in schizophrenia, sponsored by Center for Addiction and Mental Health. Started Mar 2010; status: completed.
02
Drugs
varenicline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01093365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01093365.